We are live on
!
Find out more
PG
Prostatis Group Portfolio holdings
AUM
$391M
1-Year Est. Return
20.37%
This Fund
S&P 500
This Quarter
Est. Return
-5.52%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
–
AUM
$64.2M
AUM Growth
-$60.6M
(-49%)
Cap. Flow
-$55.8M
Cap. Flow
% of AUM
-86.94%
Top 10 Holdings %
Top 10 Hldgs %
81.82%
Holding
91
New
7
Increased
19
Reduced
18
Closed
44
Top Buys
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$27.8M |
| 2 |
Amplify CWP Enhanced Dividend Income ETF
DIVO
|
+$6.1M |
| 3 |
HDV
iShares Core High Dividend ETF
HDV
|
+$5.91M |
| 4 |
Vanguard Information Technology ETF
VGT
|
+$640K |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$337K |
Top Sells
| 1 |
Vanguard Growth ETF
VUG
|
+$16.1M |
| 2 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$7.23M |
| 3 |
FT Vest Fund of Deep Buffer ETFs
BUFD
|
+$4.58M |
| 4 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$4.47M |
| 5 |
iShares ESG Optimized MSCI USA ETF
SUSA
|
+$4.41M |
Sector Composition
| 1 | Healthcare | 4.6% |
| 2 | Technology | 4.03% |
| 3 | Consumer Discretionary | 2.65% |
| 4 | Financials | 1.9% |
| 5 | Industrials | 1.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
First Trust Enhanced Short Maturity ETF
FTSM
$6.5B
| $27.7M | 43.19% |
+466,641
| New | +$27.8M |
|
|
2
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.33B
| $8.31M | 12.96% |
247,832
+171,287
| +224% | +$6.1M |
|
|
HDV
3
iShares Core High Dividend ETF
HDV
$14.2B
| $5.62M | 8.75% |
+279,555
| New | +$5.91M |
|
4
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $3.96M | 6.17% |
51,571
+2,681
| +5% | +$207K |
|
5
Thermo Fisher Scientific
TMO
$198B
| $1.58M | 2.47% |
2,911
-1,431
| -33% | -$788K |
|
6
Microsoft
MSFT
$2.93T
| $1.37M | 2.14% |
5,345
-5,010
| -48% | -$1.36M |
|
7
Apple
AAPL
$4.9T
| $1.21M | 1.89% |
8,857
-10,315
| -54% | -$1.56M |
|
8
Vanguard S&P 500 ETF
VOO
$974B
| $1.05M | 1.64% |
3,035
+10
| +0.3% | +$3.77K |
|
9
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.21B
| $839K | 1.31% |
13,691
+2,165
| +19% | +$140K |
|
10
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $837K | 1.3% |
16,704
+1,026
| +7% | +$51.9K |
|
11
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.51B
| $727K | 1.13% |
21,558
-1,904
| -8% | -$67.8K |
|
12
Home Depot
HD
$338B
| $660K | 1.03% |
2,407
-2,618
| -52% | -$773K |
|
13
Amazon
AMZN
$2.66T
| $588K | 0.92% |
5,537
-1,123
| -17% | -$141K |
|
|
14
Vanguard Information Technology ETF
VGT
$139B
| $580K | 0.9% |
+14,208
| New | +$640K |
|
15
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.4B
| $504K | 0.79% |
9,635
-47,785
| -83% | -$2.74M |
|
16
Northrop Grumman
NOC
$74.1B
| $452K | 0.7% |
944
-25
| -3% | -$11.5K |
|
17
Visa
V
$682B
| $444K | 0.69% |
2,257
+150
| +7% | +$31K |
|
18
Adams Diversified Equity Fund
ADX
$3.18B
| $409K | 0.64% |
26,682
+81
| +0.3% | +$1.34K |
|
19
Lockheed Martin
LMT
$117B
| $343K | 0.54% |
798
+102
| +15% | +$44.8K |
|
20
ExxonMobil
XOM
$611B
| $335K | 0.52% |
3,915
-386
| -9% | -$34.8K |
|
|
21
Vanguard High Dividend Yield ETF
VYM
$80B
| $316K | 0.49% |
+3,106
| New | +$337K |
|
22
iShares Core S&P Small-Cap ETF
IJR
$110B
| $311K | 0.49% |
3,370
-224
| -6% | -$22.3K |
|
23
Johnson & Johnson
JNJ
$609B
| $305K | 0.48% |
1,719
+278
| +19% | +$49.5K |
|
24
Procter & Gamble
PG
$349B
| $293K | 0.46% |
2,041
+102
| +5% | +$15.3K |
|
25
Amgen
AMGN
$198B
| $293K | 0.46% |
1,204
+39
| +3% | +$9.56K |
|
Similar funds
S
RI
CFA
SI
MA
TCM
IPW
HP
Prostatis Group's Q2 2022 Portfolio in Review
As of Q2 2022, Prostatis Group held 91 positions worth $64.2M, down 49% from $125M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Prostatis Group withdrew a net $55.8M in Q2 2022, closing 44 positions and reducing 18 holdings. Its most notable exit was Vanguard Growth ETF, an estimated $16.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 4.6% of assets, up from 4.4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Prostatis Group opened a new position in First Trust Enhanced Short Maturity ETF worth $27.7M.
- Prostatis Group's largest Q2 2022 buy was First Trust Enhanced Short Maturity ETF: 466,641 shares worth $27.7M.
- Prostatis Group added most to Amplify CWP Enhanced Dividend Income ETF in Q2 2022, an estimated $6.1M increase.
- Prostatis Group's biggest Q2 2022 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $2.74M.
- Prostatis Group fully exited Vanguard Growth ETF in Q2 2022, selling an estimated $16.1M.
- Prostatis Group's ten largest holdings make up 82% of its $64.2M portfolio in Q2 2022.
- Prostatis Group opened 7 new positions and closed 44 in Q2 2022.
- Prostatis Group's portfolio value fell 49% quarter-over-quarter to $64.2M.
Based on Prostatis Group's 13F filing for Q2 2022, filed 23 Mar 2023.